Anticardiolipin Antibodies in Children with Helicobacter pylori Infection

Serdar Umit Sarıcı1, Orhan Gursel1, Emin Kurekci1

  • 1Department of Pediatrics, Gulhane Military Medical Academy and Medical Faculty, Ankara, Turkey.

Helicobacter
|April 10, 2015
PubMed

Insights

Helicobacter pylori infection in children is linked to anticardiolipin (aCL) antibodies, which are associated with thrombosis. Eradicating H. pylori effectively reduces these aCL antibodies, suggesting a causal relationship.

Area of Science:

  • Pediatric autoimmune disorders
  • Infectious disease immunology
  • Thrombosis and hemostasis

Background:

  • Anticardiolipin (aCL) antibodies are linked to thrombotic events like stroke and myocardial infarction.
  • Helicobacter pylori (H. pylori) infection is implicated in various diseases, including autoimmune conditions.
  • A potential association between H. pylori infection and aCL antibodies warrants investigation, particularly in pediatric populations.

Purpose of the Study:

  • To investigate the prevalence of aCL antibody positivity in children with H. pylori infection.
  • To explore the relationship between H. pylori infection and anticardiolipin antibody levels.
  • To assess the impact of H. pylori eradication therapy on aCL antibody levels in children.

Main Methods:

  • Studied anticardiolipin antibody levels in 84 pediatric patients before and after H. pylori eradication therapy.
  • Included a control group of 40 children for comparison.
  • Measured aCL IgA, IgM, and IgG antibody levels using standardized assays.

Main Results:

  • Pre-treatment aCL antibody levels (IgA, IgM, IgG) in children with H. pylori infection were significantly higher compared to post-treatment levels and controls.
  • Post-treatment aCL antibody levels in the study group were not significantly different from those in the control group.
  • Successful eradication of H. pylori led to a significant decrease in anticardiolipin antibody titers.

Conclusions:

  • H. pylori infection can induce anticardiolipin antibody positivity in children.
  • Eradication of H. pylori infection results in the disappearance of anticardiolipin antibodies.
  • This suggests a causal link between H. pylori and aCL antibody production in pediatric patients.
Abstract

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
850
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.3K
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
35
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.8K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.6K
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.4K